QuestCap Inc. announce the appointment of Dr. Lawrence Steinman and Mike McCarthy to the board of advisors. Dr. Lawrence Steinman is Professor of Neurology, Neurological Sciences and Pediatrics at Stanford University and Chair of the Stanford Program in Immunology from 2001 to 2011. Mike McCarthy has more than 14 years of experience with the Ontario Ministry of Health and Long-Term Care and 24 years in health policy and delivery.

The company announce an investment of $1 million in the Sunnybrook Research Institute's COVID-19 research. With these funds, Sunnybrook will establish the Sunnybrook Translational Research Group for Emerging and Respiratory Viruses ("SERV") and QuestCap will receive a 3.5% royalty on any revenues earned by Sunnybrook from the commercialization of any of the research done by SERV. Led by infectious diseases physician and microbiologist Dr. Samira Mubareka, SERV's work will focus on three crucial streams of research: vaccines and therapeutics, virus biology and transmission prevention. Dedicated investment in SERV means Dr. Mubareka and her team will be able to accelerate the pace of further research into COVID-19 at a crucial time.